Tango Therapeutics shareholders approve doubling authorized shares to 400M, elect new director

Tango Therapeutics, Inc.

Shareholders approved amendment to increase authorized common stock from 200M to 400M shares (85.8M for, 11M against).
Lesley Ann Calhoun elected as Class I director with 73.1M votes for, 10.5M withheld.
Ratification of PricewaterhouseCoopers as auditor for FY2025 passed with 96.7M for.
Non-binding say-on-pay passed; annual advisory vote frequency approved (73M votes for one year).

item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.